- C. acnes
- S. epidermidis
- S. capitis
- S. hominis
- S. mitis
- C. simulans
- M. globosa
The following strains are typical of healthy skin in the areas where eczema most frequently occurs in adults and infants:
Sebaceous skin areas
Moist skin areas
- C. tuberculostearicum
- C. simulans
- S. epidermidis
- S. capitis
- S. hominis
- C. acnes
- M. globosa
Strains Typical of Healthy Infant Skin
- L. crispatus
- S. epidermidis
- S. mitis
- C. tuberculostearicum
- C. acnes
Test Criteria for the MyMicrobiome 27.10/11-Derm-Eczema Certification
This test ensures the microbiological purity of the product. It is screened for contamination by mesophilic and aerobic microorganisms, including bacteria, yeasts, and molds (TAMC and TYMC). The product must meet the limit of ≤ 1 x 10³ CFU per gram or milliliter to pass.
This test evaluates the product’s ability to influence the balance between the pathogenic S. aureus strain in AD and its antagonist S. hominis. To meet the standard, the product must shift the balance in favor of S. hominis while reducing the growth of S. aureus by at least 70%.
Microorganisms typical of sebaceous and moist or infant skin areas are cultured and exposed to the test product. Microbial diversity is then analyzed by comparing the treated samples to a control. To pass, the product must preserve the key microbes of the skin microbiome.
A microbiome-friendly product should not only preserve microbial diversity but also support the natural growth of beneficial microbes. A test model simulating skin contact is used. In one method, key microbes are directly exposed to the product; in another, microbes are covered with an agar layer, onto which the product is applied—simulating deeper skin penetration. Microbial growth in both test settings is compared to an untreated control. To meet the standard, the product must not significantly inhibit bacterial growth.
The MyMicrobiome 27.10/11-Derm-Eczema Standard requires targeted inhibition of S. aureus strains. Nine well-characterized S. aureus strains are incubated with the product. To obtain certification, the product must reduce the growth of the test strains by at least 70%.